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Magnetic resonance imaging for the treatment planning 
in invasive carcinoma of the cervix in pregnant women
Grzegorz Panek, Mariusz Bidziƒski, Alicja Ceran1, Ryszard Krynicki, Piotr Sobiczewski
P u r p o s e.  To evaluate magnetic resonance imaging (MRI) in the planning of optimal treatment- radiotherapy or radical
surgery in pregnant patients with invasive carcinoma of the cervix.
M a t e r i a l  a n d  m e t h o d s.  Four patients with invasive carcinoma of the cervix in pregnancy underwent MRI for evaluation
of the tumor extent with an emphasis on parametrial invasion and pelvic lymph node metastases. In all 4 patients the
diagnosis of carcinoma of the cervix was established in the first trimester of pregnancy.
Re s u l t s.  Clinical stage IB was confirmed in two patients, IIB in one patient and IA in one patient. The first patient with stage
IB disease was treated with radical Wertheim’s hysterectomy. The second patient with stage IB was found inoperable due to
bladder involvement not revealed by the MRI. This patient was subsequently treated with radiotherapy. The microscopic
examination confirmed deep infiltration of the cervical stroma as detected by preoperative MRI in the radically operated case
and the presence of metastases to the pelvic nodes in both patients, also detected by MRI.
The third patient with stage IIB disease was treated with external beam irradiation to the pelvis and intracavitary brachytherapy.
In the course of follow-up ranging from 9 to 35 months one patient recurred in the paraaortic region and was subsequently
treated with surgery and adjuvant chemotherapy.
C o n c l u s i o n.  MRI is a useful tool for noninvasive staging of pregnant patients with invasive carcinoma of the cervix. All
data suggesting a subclinical spread of the tumor outside the cervix may be helpful in selecting the optimal method of
treatment.
Ocena przydatnoÊci magnetycznego rezonansu jàdrowego w diagnostyce inwazyjnego raka szyjki macicy
wspó∏istniejàcego z cià˝à
C e l.  Celem pracy by∏a ocena przydatnoÊci magnetycznego rezonansu jàdrowego w planowaniu leczenia chorych na
inwazyjnego raka szyjki macicy, wspó∏istniejàcego z cià˝à oraz w monitorowaniu nowotworu w przypadku odroczenia terapii.
M a t e r i a ∏  i m e t o d y.  U 4 chorych z potwierdzonym mikroskopowo inwazyjnym rakiem szyjki macicy, wspó∏istniejàcym
z cià˝à, wykonano MRI miednicy w celu oceny stopnia zaawansowania nowotworu.
Wyniki badania obrazowego skorelowano ze stanem klinicznym i na tej podstawie dwie chore z nowotworem w stopniu IB oraz
jednà w stopniu IIB poddano natychmiastowemu leczeniu onkologicznemu – chirurgii lub radioterapii. W jednym przypadku,
z uwagi na rak naciekania podÊcieliska szyjki macicy, zarówno w ocenie MRI, jak i biopsji, podj´to decyzj´ o planowym
odroczeniu leczenia do rozwiàzania cià˝y i po∏ogu.
W y n i k i.  Analiza porównawcza wyników oceny mikroskopowej oraz MRI przypadków operowanych potwierdzi∏a wysokà
zgodnoÊç w zakresie oceny g∏´bokoÊci naciekania zr´bu szyjki macicy oraz stanu regionalnych w´z∏ów ch∏onnych miednicy.
W n i o s k i.  Wczesne doÊwiadczenia w∏asne potwierdzi∏y wysokà wartoÊç diagnostycznà rezonansu magnetycznego
w przypadkach raka szyjki macicy, wspó∏istniejàcego z cià˝à. Mo˝liwoÊç wykrycia szerzenia si´ procesu nowotworowego
poza szyjk´ macicy w fazie przedklinicznej pozwala na optymalizacj´ leczenia, a w szczególnych sytuacjach umo˝liwia
planowe odroczenie terapii do momentu rozwiàzania cià˝y.
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Introduction
Invasive carcinoma of the cervix complicating pregnancy
is a rare clinical entity. The estimated rate of this
malignancy ranges from 0.3 to 0.5% of live deliveries [1].
This particular clinical situation is highly challenging
for the treating team. The optimal therapeutic decision
can be made after a very careful consideration of all
important prognostic factors of the tumor, age of
pregnancy and the will of the pregnant woman. The
diagnosis of invasive cervical cancer in early pregnancy
warrants immediate treatment inevitably leading to fetal
loss. There are, however, women who place such a high
value on pregnancy, that they are willing to undertake
the risk of delaying the treatment until the fetus is mature.
This very personal decision requires counseling by the
gynecologist-oncologist and obstetrician regarding the
risks both to the fetus and the mother.
Accurate staging is the main determinant in
managing patients with cervical cancer and has been
estimated by the clinical FIGO staging system. However,
the discrepancy between clinical staging and surgical
staging is found in 17 to 32% of patients with stage IB
disease. The inaccuracy of clinical staging is even more
apparent in pregnant patients due to hyperaemia and
oedema of the pelvic tissues.
Recent reports show the superiority of MRI over
clinical staging [2-5]. A relative lack of teratogenic effect
of MRI even after repeated examinations and high tissue
resolution make this imaging technique optimal for pre-
treatment evaluation of pregnant women with invasive
carcinoma of the cervix [2].
In this report the authors present their preliminary
experience with the use of MRI for pretreatment
evaluation and management of carcinoma of the cervix in
pregnant women.
Material and methods
Between 1998 and 2001 four pregnant women with carcinoma of
the cervix were admitted to Department of Gynecological
Oncology of the Maria Sklodowska-Curie Memorial Cancer
Center and Institute of Oncology in Warsaw for pre-treatment
evaluation or definitive therapy. In all cases the diagnosis was
established in the first trimester – between the 6th and the 11th
week of pregnancy. After a routine staging workout including
clinical examination and abdominal ultrasound the diagnosis
of stage IA (FIGO) was established in 1 case, IB in two cases,
and IIB in one case. For further confirmation of the stage of
the disease in all patients pelvic MRI examination was carried
out using a Philips Gyroscan ACS-NT 1.5T with the following
imaging parameters: T1/TSE/512; TE 14ms; TR 500ms; 
NSA 6 acquisitions
T2/TSE/512; TE 150ms
STIR; TE 100ms; TR 1800ms; TR 150ms;
NSA-3
The images were obtained in the frontal, sagittal and
transversal projection.
For the contrast enhanced images Gd-DTPA with the dose
of 0.2 ml/kg was administered.
In the MRI evaluation of pregnant women with carcinoma
of the cervix special attention was paid to the following
prognostic parameters: depth of cervical infiltration, parametrial
or vaginal involvement, rectal or bladder involvement and pelvic
lymphnode status.
Figures 1 and 2 present a MRI image of stage IB cervical
cancer in a pregnant woman and the surgical specimen.
After completing the staging procedure one patient with
stage IB disease was treated with radical Wertheim-Meig’s
250
Figure 1. Surgical specimen presenting the transected uterus with
cervical infiltration and the foetus
Figure 2. T2 image of pregnant uterus with cervical infiltration of the tumor
hysterectomy, while the second patient with clinical stage IB
confirmed by MRI underwent laparotomy. In this case radical
hysterectomy had been abandoned due to infiltration of the
bladder. The patient subsequently underwent a course of chemo-
radiotherapy with the dose of 50 Gy to the pelvis with weekly
cisplatin 30 mg\kg. The third patient with stage IIB disease was
treated with radiotherapy consisting of pelvic external beam
irradiation to the dose of 45 Gy and intracavitary brachytherapy
Cs.137/LDR with the dose of 40 Gy in the reference point A.
The fourth patient with stage IA disease was followed up to the
term delivery. Definitive treatment in the form of amputation of
the cervix was carried out 6 weeks postpartum.
All patients were followed up regularly after completion of
the treatment for 12, 16, 18 and 30 months.
Results
After a pretreatment staging work-out stage IB invasive
carcinoma of the cervix was diagnosed in two cases, IIB in
one case and IA in one case.
In subject one MRI revealed an infiltrate of the
cervix with the diameter of 30 mm with a deep infiltration
of the cervical stroma of more than 50% of its thickness.
The stromal ring at MRI had the thickness of 3 mm,
suggesting uninvolved parametria. There was no sign of
pelvic lymphadenopathy. The patient underwent radical
hysterectomy at the 15th week of gestation. The pathologic
specimen confirmed the existence of a tumor measuring
27x16x18 mm. Both parametria and the vaginal cuff were
free of the tumor. The pelvic nodes were also negative for
metastases.
The second patient had a stage IB disease diagnosed
at the 9th week of gestation. MRI showed a bulky tumor
of the cervix with the diameter of 38x22x18 mm with no
obvious parametrial involvement or pelvic lympha-
denopathy. The patient was referred for radical hystere-
ctomy. At the time of laparotomy a deep infiltration of
the uterine isthmus with infiltration of the bladder was
found. Due to these findings radical hysterectomy was
abandoned and the patient was treated with radiotherapy.
The third subject had stage IIB disease diagnosed
at the 9th week of gestation. Clinical examination revealed
a bulky tumor of the cervix with proximal parametrial
involvement. On MRI examination a tumor with thinning
of the stromal ring, suggesting left parametrial invasion
was detected. This patient was treated from eleventh
week of gestation with radiotherapy consisting of external
beam and intracavitary irradiation.
The fourth patient had a stage IA1 tumor (with focal
invasion up to 2 mm) diagnosed in the 16th week of
pregnancy. MRI confirmed the existence of a relatively
small primary tumor of the cervix measuring 4x6 mm
without infiltration of stromal ring. Basing on clinical,
microscopic and radiological findings a decision was made
to continue pregnancy. A repeated biopsy of the cervix
and MRI on 32nd week of gestation confirmed stable
disease with no sign of progression. The patient delivered
by caesarean section in the 38th week of gestation and 6
weeks later amputation of the cervix was performed.
Microscopic examination of the surgical specimen
confirmed the presence of the tumor measuring 6x4 mm
with the depth of stromal invasion of less than 2 mm.
Table I summarizes the main characteristics of the
patients and their outcomes.
Discussion
The diagnosis of invasive cervical cancer in pregnancy is
an uncommon clinical situation which poses a difficult
situation both for the woman and her doctor. When
detected in the first trimester, cervical cancer can be
treated either by radical surgery or radiotherapy. Both
methods of treatment may result in termination of
pragnancy with ultimate loss of procreation potential.
Diagnosis during the second trimester poses the most
difficult clinical challenges. The decision whether to
inniciate treatment immediately or delay the treatment
until foetus maturity should be based on the most precise
data concerning the extent of the disease. Continuation of
pregnancy without treatment could hardly be suggested to
patients with parametrial infiltration or lymph node
metastases. Staging based purely on clinical examination
is not a reliable source of important prognostic factors,
due to hyperaemia and oedema of the pelvic tissues
associated with pregnancy [6-8]. Modern imaging
techniques, such as ultrasonography have proven not to
be a reliable staging tool in patients with cervical cancer.
Computed tomography with an inevitable exposure of
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Table I. Clinical features of the patients
1 2 3 4
Age 24 29 31 32
FIGO stage IB IA IIB IB
Gestation age (weeks) 6 11 9 8
Treatment radical hysterectomy trachelectomy puerperium rth* explorative surgery + rth*
Treatment delay (weeks) 0 25 0 0
Microscopic exam 18 mm 2 mm - -
Stromal invasion
Stromal invasion MRI 15 mm 0 mm 25 mm 22 mm
Pelvic nodes microscope N (-) - - N (+)
Pelvic nodes MRI N (-) N (-) N (+) N (+)
* radiotherapy
the foetus to irradiation is contraindicated in the first
trimester [9, 10]. The latest reports have shown that MRI
provides the best conditions to accurately define the
extension of the tumor [11, 12]. The relative safety of this
imaging technique even in the first trimester of pregnancy
renders MRI the optimal method of pre-treatment
evaluation of pregnant women with invasive carcinoma of
the cervix [10, 11].
Tumor volume and tumor dimensions, depth of
invasion of the cervical stroma and parametrial invol-
vement are important prognostic factors on which to base
the therapeutic decision concerning the method and the
timing of treatment. Most investigators have found very
good correlations of MRI findings with the results of
measurements of the surgical specimen [13, 14]. Our data
has shown an excellent correlation of pre treatment
measurements with postoperative data even in the case of
early invasive cancer. Some authors indicate that MRI
tends to overestimate tumor volume by 10-35% [10, 11 ].
This inconsistency can be attributed to the inability of
MRI differentiation between tissue oedema and tumor
invasion [10, 11 ]. In our experience MRI failed to detect
an infiltration of the vesico-cervical septum found
intraoperatively. The status of the pelvic lymph nodes is
the most important prognostic factor affecting the survival
of patients with carcinoma of the cervix. The detection of
positive pelvic nodes in the pre-treatment evaluation of
pregnant women is crucial for selecting the patients for
immediate or delayed therapy. The application of
ultrasound and CT scan for assessing pelvic lymph nodes
has been proven to bear a significant error [11]. More
recent reports have shown significantly better consistency
of MRI findings with microscopic examination of the
nodes dissected at the time of surgery, with its sensitivity
reaching approximately 60% and specificity exceeding
80% [10]. A limited number of cases in this report
precluded any conclusive analysis, however it is worth to
emphasize the 100% specificity of MRI in detecting node
negative patients. The detection of macroscopic lymph
node metastases on MRI is a contraindication to planned
delay of treatment. There is an individual report
advocating the use of neoadjuvant chemotherapy in
patients wishing to continue pregnancy even in the
presence of unfavourable prognostic factors, such as gross
cervical tumor, suspect pelvic nodes or highly malignant
histopathology [12-14]. The authors of the report
emphasize the fact that the decision to start chemo-
therapy in the course of pregnancy was undertaken in
circumstances under which the patient had decided to
continue pregnancy despite the presence of a highly
malignant tumor.
Because of a relative rarity of carcinoma of the cervix
associated with pregnancy there are some limitations to
the final assessment of MRI value in this particular
clinical situation. Our early experience remains in
accordance with other reports, as it confirms the value
of MRI in the management of cervical cancer in
pregnancy through providing important prognostic
information on which the optimal therapeutic decision
can be based.
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